The insulin-sensitizing agent troglitazone improves metabol and reproductive abnormalities in the polycystic ovary syndrome. - Dunaif,A.; Scott,D.; Finegood,D.; Quintana,B.; Whitcomb,R. (J Clin Endocrinol Metab, 1996)